What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 18.5% in the pre-market session after ...

Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what ...

Law Offices of Howard G. Smith announces an investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company’s possible ...

Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) shares traded down 5.5% during trading on Wednesday after Evercore ISI lowered their price target on the stock from $20.00 to $15.00.

Fortrea Holdings Inc (NASDAQ:FTRE) achieved a strong book-to-bill ratio of 1.35 in the fourth quarter, indicating robust demand and successful sales efforts. The company's backlog has grown to $7. ...

FORTREA ($FTRE) posted quarterly earnings results on Monday, March 3rd. The company reported earnings of $0.18 per share, missing estimates of $0.37 by $0.19. The ...

In a report released today, Max Smock from William Blair maintained a Hold rating on Fortrea Holdings Inc. (FTRE – Research Report). The ...

Fortrea (NASDAQ:FTRE – Free Report) had its target price lowered by Evercore ISI from $20.00 to $15.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The firm ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

$FTRE insiders have traded $FTRE stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales. We have seen 115 ...

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 18.5% in the pre-market session after the company delivered weak fourth-quarter 2024 results, with sales, operating profits ...